| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bms 275291 | matrix metalloproteinase-1 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Kaposi Sarcoma[MeSHID:D012514] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | discontinued in phase 3 | unknown |
| bms 275291 | matrix metalloproteinase-2 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Kaposi Sarcoma[MeSHID:D012514] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | discontinued in phase 3 | unknown |
| bms 275291 | matrix metalloproteinase-7 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Kaposi Sarcoma[MeSHID:D012514] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | discontinued in phase 3 | unknown |
| click here to return to the previous page | ||||||||